The only legal access is through clinical trials or, in extreme cases, expanded access
Research shows that GLP-1 medications paired with growth hormone-releasing peptides like Sermorelin can help preserve muscle mass during weight loss
While GLP-1RAs demonstrate promising metabolic and anti-inflammatory effects, their application in treating sepsis remains limited by insufficient clinical evidence, individual variability, and potential side effects
It is designed to help support weight loss, control appetite, improve metabolism, and manage chronic obesity
Kidney or Liver Impairment No specific dose adjustments are recommended for mild-to-moderate renal or hepatic impairment based on tirzepatide data (similar peptide)
They are the second late-stage results to date on retatrutide, which works differently from existing injections and appears to be more effective, at least for weight loss